Comparing in situ removal strategies for improving styrene bioproduction

Rebekah McKenna, Luis Moya, Matthew McDaniel, David Nielsen

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

As an important conventional monomer compound, the biological production of styrene carries significant promise with respect to creating novel sustainable materials. Since end-product toxicity presently limits styrene production by previously engineered Escherichia coli, in situ product removal by both solvent extraction and gas stripping were explored as process-based strategies for circumventing its inhibitory effects. In solvent extraction, the addition of bis(2-ethylhexyl)phthalate offered the greatest productivity enhancement, allowing net volumetric production of 836 ± 64 mg/L to be reached, representing a 320 % improvement over single-phase cultures. Gas stripping rates, meanwhile, were controlled by rates of bioreactor agitation and, to a greater extent, aeration. A periodic gas stripping protocol ultimately enabled up to 561 ± 15 mg/L styrene to be attained. Lastly, by relieving the effects of styrene toxicity, new insight was gained regarding subsequent factors limiting its biosynthesis in E. coli and strategies for future strain improvement are discussed.

Original languageEnglish (US)
Pages (from-to)165-174
Number of pages10
JournalBioprocess and Biosystems Engineering
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Styrene
Gases
Solvent extraction
Escherichia coli
Toxicity
Diethylhexyl Phthalate
Biosynthesis
Bioreactors
Monomers
Productivity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Comparing in situ removal strategies for improving styrene bioproduction. / McKenna, Rebekah; Moya, Luis; McDaniel, Matthew; Nielsen, David.

In: Bioprocess and Biosystems Engineering, Vol. 38, No. 1, 01.01.2015, p. 165-174.

Research output: Contribution to journalArticle

McKenna, Rebekah ; Moya, Luis ; McDaniel, Matthew ; Nielsen, David. / Comparing in situ removal strategies for improving styrene bioproduction. In: Bioprocess and Biosystems Engineering. 2015 ; Vol. 38, No. 1. pp. 165-174.
@article{49a934dea2c243da924ef605121ec7a4,
title = "Comparing in situ removal strategies for improving styrene bioproduction",
abstract = "As an important conventional monomer compound, the biological production of styrene carries significant promise with respect to creating novel sustainable materials. Since end-product toxicity presently limits styrene production by previously engineered Escherichia coli, in situ product removal by both solvent extraction and gas stripping were explored as process-based strategies for circumventing its inhibitory effects. In solvent extraction, the addition of bis(2-ethylhexyl)phthalate offered the greatest productivity enhancement, allowing net volumetric production of 836 ± 64 mg/L to be reached, representing a 320 {\%} improvement over single-phase cultures. Gas stripping rates, meanwhile, were controlled by rates of bioreactor agitation and, to a greater extent, aeration. A periodic gas stripping protocol ultimately enabled up to 561 ± 15 mg/L styrene to be attained. Lastly, by relieving the effects of styrene toxicity, new insight was gained regarding subsequent factors limiting its biosynthesis in E. coli and strategies for future strain improvement are discussed.",
author = "Rebekah McKenna and Luis Moya and Matthew McDaniel and David Nielsen",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/s00449-014-1255-9",
language = "English (US)",
volume = "38",
pages = "165--174",
journal = "Bioprocess and Biosystems Engineering",
issn = "1615-7591",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Comparing in situ removal strategies for improving styrene bioproduction

AU - McKenna, Rebekah

AU - Moya, Luis

AU - McDaniel, Matthew

AU - Nielsen, David

PY - 2015/1/1

Y1 - 2015/1/1

N2 - As an important conventional monomer compound, the biological production of styrene carries significant promise with respect to creating novel sustainable materials. Since end-product toxicity presently limits styrene production by previously engineered Escherichia coli, in situ product removal by both solvent extraction and gas stripping were explored as process-based strategies for circumventing its inhibitory effects. In solvent extraction, the addition of bis(2-ethylhexyl)phthalate offered the greatest productivity enhancement, allowing net volumetric production of 836 ± 64 mg/L to be reached, representing a 320 % improvement over single-phase cultures. Gas stripping rates, meanwhile, were controlled by rates of bioreactor agitation and, to a greater extent, aeration. A periodic gas stripping protocol ultimately enabled up to 561 ± 15 mg/L styrene to be attained. Lastly, by relieving the effects of styrene toxicity, new insight was gained regarding subsequent factors limiting its biosynthesis in E. coli and strategies for future strain improvement are discussed.

AB - As an important conventional monomer compound, the biological production of styrene carries significant promise with respect to creating novel sustainable materials. Since end-product toxicity presently limits styrene production by previously engineered Escherichia coli, in situ product removal by both solvent extraction and gas stripping were explored as process-based strategies for circumventing its inhibitory effects. In solvent extraction, the addition of bis(2-ethylhexyl)phthalate offered the greatest productivity enhancement, allowing net volumetric production of 836 ± 64 mg/L to be reached, representing a 320 % improvement over single-phase cultures. Gas stripping rates, meanwhile, were controlled by rates of bioreactor agitation and, to a greater extent, aeration. A periodic gas stripping protocol ultimately enabled up to 561 ± 15 mg/L styrene to be attained. Lastly, by relieving the effects of styrene toxicity, new insight was gained regarding subsequent factors limiting its biosynthesis in E. coli and strategies for future strain improvement are discussed.

UR - http://www.scopus.com/inward/record.url?scp=84925939992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925939992&partnerID=8YFLogxK

U2 - 10.1007/s00449-014-1255-9

DO - 10.1007/s00449-014-1255-9

M3 - Article

C2 - 25034182

AN - SCOPUS:84925939992

VL - 38

SP - 165

EP - 174

JO - Bioprocess and Biosystems Engineering

JF - Bioprocess and Biosystems Engineering

SN - 1615-7591

IS - 1

ER -